Global Latent Tuberculosis Infection (LTBI) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Latent Tuberculosis Infection (LTBI) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.

Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.

Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.

According to our (Global Info Research) latest study, the global Latent Tuberculosis Infection (LTBI) Testing market size was valued at US$ 1521 million in 2023 and is forecast to a readjusted size of USD 2170 million by 2030 with a CAGR of 5.3% during review period.

The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.

Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.

Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.

This report is a detailed and comprehensive analysis for global Latent Tuberculosis Infection (LTBI) Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Latent Tuberculosis Infection (LTBI) Testing market size and forecasts, in consumption value ($ Million), 2019-2030

Global Latent Tuberculosis Infection (LTBI) Testing market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Latent Tuberculosis Infection (LTBI) Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Latent Tuberculosis Infection (LTBI) Testing market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Latent Tuberculosis Infection (LTBI) Testing

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Latent Tuberculosis Infection (LTBI) Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, Par Sterile, Bio-Rad Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)

Market segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others

Market segment by players, this report covers
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Latent Tuberculosis Infection (LTBI) Testing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Latent Tuberculosis Infection (LTBI) Testing, with revenue, gross margin, and global market share of Latent Tuberculosis Infection (LTBI) Testing from 2019 to 2024.

Chapter 3, the Latent Tuberculosis Infection (LTBI) Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Latent Tuberculosis Infection (LTBI) Testing market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Latent Tuberculosis Infection (LTBI) Testing.

Chapter 13, to describe Latent Tuberculosis Infection (LTBI) Testing research findings and conclusion.